Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-02-08 Purchase |
2024-02-12 6:23 pm |
Jasper Therapeutics Inc. | JSPR | Carlyle Group Inc. Carlyle Holdings I GP Inc. Carlyle Holdings I GP Sub L.L.C. Carlyle Holdings I L.P. CG Subsidiary Holdings L.L.C. TC Group LLC Carlyle Investment Management LLC Carlyle Genesis UK LLC Abingworth LLP Abingworth Bioventures VII LP Former 10% Owner |
190,000 | $12.95 | $2,460,500 | 1,066,189 (Indirect) |
View |
| 2023-01-27 Purchase |
2023-01-31 5:24 pm |
Jasper Therapeutics Inc. | JSPR | Carlyle Group Inc. Abingworth LLP Carlyle Holdings I GP Inc. Carlyle Holdings I GP Sub L.L.C. Carlyle Holdings I L.P. CG Subsidiary Holdings L.L.C. TC Group LLC Carlyle Investment Management LLC Carlyle Genesis UK LLC 10% Owner |
3,133,333 | $1.5 | $4,700,000 | 8,761,891 (Indirect) |
View |
| 2022-08-17 Sale |
2022-08-19 4:39 pm |
Vera Therapeutics Inc. | VERA | Carlyle Group Inc. Abingworth LLP Abingworth Bioventures 8 LP Carlyle Holdings I GP Inc. Carlyle Holdings I GP Sub L.L.C. Carlyle Holdings I L.P. CG Subsidiary Holdings L.L.C. TC Group LLC Carlyle Investment Management LLC Carlyle Genesis UK LLC 10% Owner |
9,925 | $20.25 | $201,026 | 2,960,231 (Indirect) |
View |
| 2022-03-29 Purchase |
2022-03-31 5:31 pm |
SOLENO THERAPEUTICS INC | SLNO | Abingworth LLP 10% Owner |
7,720,000 | $0 | $0 | 25,856,994 (Indirect) |
View |
| 2022-01-31 Purchase |
2022-02-01 5:00 pm |
Sierra Oncology Inc. | SRRA | Abingworth LLP 10% Owner |
150,000 | $27 | $4,050,000 | 1,314,127 (Indirect) |
View |
| 2021-05-18 Purchase |
2021-05-18 6:00 pm |
Vera Therapeutics Inc. | VERA | Abingworth LLP 10% Owner |
772,727 | $11 | $8,499,997 | 2,970,156 (Indirect) |
View |
| 2020-10-20 Sale |
2020-10-21 4:05 pm |
Personalis Inc. | PSNL | Abingworth LLP Former 10% Owner |
130,486 | $27.66 | $3,609,243 | 3,753,340 (Indirect) |
View |
| 2020-10-16 Sale |
2020-10-20 4:06 pm |
Personalis Inc. | PSNL | Abingworth LLP 10% Owner |
290,641 | $27.48 | $7,986,081 | 3,883,826 (Indirect) |
View |
| 2020-10-14 Sale |
2020-10-16 4:05 pm |
Personalis Inc. | PSNL | Abingworth LLP 10% Owner |
85,625 | $27.05 | $2,315,913 | 4,174,467 (Indirect) |
View |
| 2020-10-12 Sale |
2020-10-14 4:05 pm |
Personalis Inc. | PSNL | Abingworth LLP 10% Owner |
202,360 | $28.81 | $5,829,352 | 4,260,092 (Indirect) |
View |
| 2020-08-18 Sale |
2020-08-20 4:00 pm |
Personalis Inc. | PSNL | Abingworth LLP 10% Owner |
986,842 | $19 | $18,749,998 | 4,462,452 (Indirect) |
View |
| 2020-06-26 Purchase |
2020-07-06 4:02 pm |
SOLENO THERAPEUTICS INC | SLNO | Abingworth LLP 10% Owner |
3,333,330 | $1.65 | $5,499,995 | 10,302,602 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-09-28 Conversion |
2023-10-02 7:54 pm |
N/A N/A |
SOLENO THERAPEUTICS INC | SLNO | Carlyle Group Inc. Carlyle Holdings I GP Inc. Carlyle Holdings I GP Sub L.L.C. Carlyle Holdings I L.P. CG Subsidiary Holdings L.L.C. TC Group LLC Carlyle Investment Management LLC Carlyle Genesis UK LLC Abingworth LLP Abingworth Bioventures VII LP 10% Owner |
1,092,056 | $0 | 2,293,562 (Indirect) |
View |
| 2023-09-28 Conversion |
2023-10-02 7:54 pm |
N/A N/A |
SOLENO THERAPEUTICS INC | SLNO | Carlyle Group Inc. Carlyle Holdings I GP Inc. Carlyle Holdings I GP Sub L.L.C. Carlyle Holdings I L.P. CG Subsidiary Holdings L.L.C. TC Group LLC Carlyle Investment Management LLC Carlyle Genesis UK LLC Abingworth LLP Abingworth Bioventures VII LP 10% Owner |
1,092,056 | $1.75 | 2,293,562 (Indirect) |
View |
| 2022-08-17 Exercise |
2022-08-19 4:39 pm |
N/A N/A |
Vera Therapeutics Inc. | VERA | Carlyle Group Inc. Abingworth LLP Abingworth Bioventures 8 LP Carlyle Holdings I GP Inc. Carlyle Holdings I GP Sub L.L.C. Carlyle Holdings I L.P. CG Subsidiary Holdings L.L.C. TC Group LLC Carlyle Investment Management LLC Carlyle Genesis UK LLC 10% Owner |
9,925 | $11 | 2,960,231 (Indirect) |
View |
| 2022-08-17 Exercise |
2022-08-19 4:39 pm |
N/A 2031-05-12 |
Vera Therapeutics Inc. | VERA | Carlyle Group Inc. Abingworth LLP Abingworth Bioventures 8 LP Carlyle Holdings I GP Inc. Carlyle Holdings I GP Sub L.L.C. Carlyle Holdings I L.P. CG Subsidiary Holdings L.L.C. TC Group LLC Carlyle Investment Management LLC Carlyle Genesis UK LLC 10% Owner |
9,925 | $0 | 2,960,231 (Indirect) |
View |
| 2018-12-21 Option Award |
2022-03-31 5:31 pm |
N/A 2028-12-21 |
SOLENO THERAPEUTICS INC | SLNO | Abingworth LLP 10% Owner |
114,392 | $0 | 25,856,994 (Indirect) |
View |
| 2022-03-21 Option Award |
2022-03-23 5:30 pm |
N/A 2032-03-21 |
Jasper Therapeutics Inc. | JSPR | Abingworth LLP 10% Owner |
78,045 | $0 | 78,045 (Indirect) |
View |
| 2022-01-28 Exercise |
2022-02-01 5:00 pm |
N/A N/A |
Sierra Oncology Inc. | SRRA | Abingworth LLP 10% Owner |
287,471 | $13.2 | 1,314,127 (Indirect) |
View |
| 2022-01-28 Exercise |
2022-02-01 5:00 pm |
2020-01-22 N/A |
Sierra Oncology Inc. | SRRA | Abingworth LLP 10% Owner |
287,471 | $0 | 1,314,127 (Indirect) |
View |
| 2021-10-06 Option Award |
2021-12-17 4:30 pm |
N/A 2031-10-05 |
eFFECTOR Therapeutics Inc. | EFTR | Abingworth LLP 10% Owner |
40,000 | $0 | 40,000 (Indirect) |
View |
Ownership |
2021-11-05 4:44 pm |
N/A N/A |
Sierra Oncology Inc. | SRRA | Abingworth LLP 10% Owner |
0 | $0 | 2,051,626 (Indirect) |
View |
Ownership |
2021-10-01 4:30 pm |
N/A N/A |
Jasper Therapeutics Inc. | JSPR | Abingworth LLP 10% Owner |
0 | $0 | 5,628,558 (Indirect) |
View |
Ownership |
2021-08-27 6:31 pm |
N/A N/A |
eFFECTOR Therapeutics Inc. | EFTR | Abingworth LLP 10% Owner |
0 | $0 | 5,427,452 (Indirect) |
View |
| 2021-05-18 Conversion |
2021-05-18 6:00 pm |
N/A N/A |
Vera Therapeutics Inc. | VERA | Abingworth LLP 10% Owner |
2,187,504 | $0 | 2,970,156 (Indirect) |
View |
| 2021-05-13 Option Award |
2021-05-18 6:00 pm |
N/A 2031-05-12 |
Vera Therapeutics Inc. | VERA | Abingworth LLP 10% Owner |
9,925 | $0 | 2,970,156 (Indirect) |
View |
Ownership |
2021-05-13 7:28 pm |
N/A N/A |
Vera Therapeutics Inc. | VERA | Abingworth LLP 10% Owner |
0 | $0 | 2,187,504 (Indirect) |
View |
| 2020-06-11 Option Award(A) |
2020-06-16 6:26 pm |
N/A 2030-06-10 |
Vaxcyte Inc. | PCVX | Abingworth LLP 10% Owner |
40,000 | $0 | 40,000 (Indirect) |
View |
| 2020-06-11 Option Award |
2020-06-15 4:41 pm |
N/A 2030-06-10 |
Vaxcyte Inc. | PCVX | Abingworth LLP 10% Owner |
40,000 | $0 | 40,000 (Indirect) |
View |
Ownership |
2020-06-11 8:52 pm |
N/A N/A |
Vaxcyte Inc. | PCVX | Abingworth LLP 10% Owner |
0 | $0 | 4,156,218 (Indirect) |
View |